Actos Drugmakers Want Rehearing in $7B ‘Class-Action Behemoth’
Media Mention: Law.com ($)
This site uses cookies for performance, site traffic analysis, and social media purposes. Find out more about our cookie policy here. You can adjust your preferences in cookie settings.
